Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Molecular Cancer Therapeutics
|
August 13, 2009
Enhanced targeting with heterobivalent ligands
Liping Xu, Josef Vagner, Jatinder Josan, et al.
Biochemical and Biophysical Research Communications
|
January 6, 2022
Alternaria alternata-induced airway epithelial signaling and inflammatory responses via protease-activated receptor-2 expression
Candy M Rivas, Hillary V Schiff, Aubin Moutal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 8, 2013
Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering
Andrea N Flynn, Justin Hoffman, Dipti V Tillu, et al.
Journal of Medicinal Chemistry
|
October 21, 2011
Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand
Natalie M Barkey, Narges K Tafreshi, Jatinder S Josan, et al.
Journal of Medicinal Chemistry
|
December 20, 2007
Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor
Alexander V Mayorov, Minying Cai, Erin S Palmer, et al.
British Journal of Pharmacology
|
November 29, 2021
Proteinase-activated receptor-2 antagonist C391 inhibits Alternaria-induced airway epithelial signalling and asthma indicators in acute exposure mouse models
Candy M Rivas, Michael C Yee, Kenneth J Addison, et al.
British Journal of Pharmacology
|
July 4, 2015
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo
Scott Boitano, Justin Hoffman, Andrea N Flynn, et al.
Journal of Medicinal Chemistry
|
June 22, 2010
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists
Takashi Yamamoto, Padma Nair, Neil E Jacobsen, et al.
British Journal of Pharmacology
|
June 23, 2022
β-Arrestin-biased proteinase-activated receptor-2 antagonist C781 limits allergen-induced airway hyperresponsiveness and inflammation
Hillary V Schiff, Candy M Rivas, William P Pederson, et al.
Cancer Research
|
December 21, 2010
A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes
Narges K Tafreshi, Steven A Enkemann, Marilyn M Bui, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Molecular Cancer Therapeutics
|
August 13, 2009
Enhanced targeting with heterobivalent ligands
Liping Xu, Josef Vagner, Jatinder Josan, et al.
Biochemical and Biophysical Research Communications
|
January 6, 2022
Alternaria alternata-induced airway epithelial signaling and inflammatory responses via protease-activated receptor-2 expression
Candy M Rivas, Hillary V Schiff, Aubin Moutal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 8, 2013
Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering
Andrea N Flynn, Justin Hoffman, Dipti V Tillu, et al.
Journal of Medicinal Chemistry
|
October 21, 2011
Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand
Natalie M Barkey, Narges K Tafreshi, Jatinder S Josan, et al.
Journal of Medicinal Chemistry
|
December 20, 2007
Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor
Alexander V Mayorov, Minying Cai, Erin S Palmer, et al.
British Journal of Pharmacology
|
November 29, 2021
Proteinase-activated receptor-2 antagonist C391 inhibits Alternaria-induced airway epithelial signalling and asthma indicators in acute exposure mouse models
Candy M Rivas, Michael C Yee, Kenneth J Addison, et al.
British Journal of Pharmacology
|
July 4, 2015
The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo
Scott Boitano, Justin Hoffman, Andrea N Flynn, et al.
Journal of Medicinal Chemistry
|
June 22, 2010
Improving metabolic stability by glycosylation: bifunctional peptide derivatives that are opioid receptor agonists and neurokinin 1 receptor antagonists
Takashi Yamamoto, Padma Nair, Neil E Jacobsen, et al.
British Journal of Pharmacology
|
June 23, 2022
β-Arrestin-biased proteinase-activated receptor-2 antagonist C781 limits allergen-induced airway hyperresponsiveness and inflammation
Hillary V Schiff, Candy M Rivas, William P Pederson, et al.
Cancer Research
|
December 21, 2010
A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes
Narges K Tafreshi, Steven A Enkemann, Marilyn M Bui, et al.
Page
of 8